Terms: = Pancreatic cancer AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Prognosis
13 results:
1. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.
Detlefsen S; Boldt HB; Burton M; Thomsen MM; Rasmussen LG; Ørbeck SV; Pfeiffer P; Mortensen MB; de Stricker K
Hum Pathol; 2023 Dec; 142():68-80. PubMed ID: 37977512
[TBL] [Abstract] [Full Text] [Related]
2. Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
Karamitopoulou E; Wenning AS; Acharjee A; Zlobec I; Aeschbacher P; Perren A; Gloor B
Gut; 2023 Aug; 72(8):1523-1533. PubMed ID: 36792355
[TBL] [Abstract] [Full Text] [Related]
3. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms of development and progression of pancreatic neoplasms.
Furukawa T
Pathol Int; 2022 Nov; 72(11):529-540. PubMed ID: 36161420
[TBL] [Abstract] [Full Text] [Related]
6. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
Yang Y; Ding Y; Gong Y; Zhao S; Li M; Li X; Song G; Zhai B; Liu J; Shao Y; Zhu L; Pang J; Ma Y; Ou Q; Wu X; Zhang Z
BMC Cancer; 2022 Feb; 22(1):186. PubMed ID: 35180847
[TBL] [Abstract] [Full Text] [Related]
7. Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.
Zhu LL; Wu Z; Li RK; Xing X; Jiang YS; Li J; Wang YH; Hu LP; Wang X; Qin WT; Sun YW; Zhang ZG; Yang Q; Jiang SH
Int J Biol Sci; 2021; 17(1):107-118. PubMed ID: 33390837
[TBL] [Abstract] [Full Text] [Related]
8. Integrated Genomic Characterization of pancreatic Ductal Adenocarcinoma.
;
Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
[TBL] [Abstract] [Full Text] [Related]
9. Intraductal neoplasms of the pancreas.
Klöppel G; Basturk O; Schlitter AM; Konukiewitz B; Esposito I
Semin Diagn Pathol; 2014 Nov; 31(6):452-466. PubMed ID: 25282472
[TBL] [Abstract] [Full Text] [Related]
10. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications.
Reid MD; Saka B; Balci S; Goldblum AS; Adsay NV
Am J Clin Pathol; 2014 Feb; 141(2):168-80. PubMed ID: 24436263
[TBL] [Abstract] [Full Text] [Related]
11. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
[TBL] [Abstract] [Full Text] [Related]
12. Classification, morphology and molecular pathology of premalignant lesions of the pancreas.
Cooper CL; O'Toole SA; Kench JG
Pathology; 2013 Apr; 45(3):286-304. PubMed ID: 23442735
[TBL] [Abstract] [Full Text] [Related]
13. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.
Furukawa T; Kuboki Y; Tanji E; Yoshida S; Hatori T; Yamamoto M; Shibata N; Shimizu K; Kamatani N; Shiratori K
Sci Rep; 2011; 1():161. PubMed ID: 22355676
[TBL] [Abstract] [Full Text] [Related]
